Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled Trial.
Frances R LevinJohn J MarianiMartina PavlicovaC Jean ChoiCale BasarabaAmy L MahonyDaniel J BrooksChristina A BrezingNasir NaqviPublished in: Journal of attention disorders (2024)
MAS-ER was generally well-tolerated. The small sample size precluded a determination of MAS-ER's superiority reducing ADHD symptoms or promoting abstinence. Notably, MAS-ER significantly reduced weekly days of use over time.
Keyphrases
- attention deficit hyperactivity disorder
- double blind
- autism spectrum disorder
- endoplasmic reticulum
- estrogen receptor
- breast cancer cells
- working memory
- placebo controlled
- clinical trial
- study protocol
- randomized controlled trial
- molecularly imprinted
- solid phase extraction
- high resolution
- sleep quality
- depressive symptoms
- tandem mass spectrometry
- simultaneous determination